TGFB1 and acute respiratory distress syndrome: Apart from genetic modification, a series of preconditioning strategies has been developed to enhance the therapeutic effect of MSCs in animal ARDS models, including preconditioning with hypoxia, serum from ARDS patients, N-acetylcysteine, TGF-β, and 3-dimensional culture.